Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 17
2004 17
2005 33
2006 43
2007 89
2008 99
2009 132
2010 156
2011 194
2012 221
2013 231
2014 328
2015 352
2016 396
2017 414
2018 516
2019 670
2020 809
2021 979
2022 1077
2023 468

Text availability

Article attribute

Article type

Publication date

Search Results

6,459 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. Among authors: li n. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Where it all started.
Zhang L, Li N, Xu R. Zhang L, et al. Among authors: li n. Elife. 2023 Apr 5;12:e87355. doi: 10.7554/eLife.87355. Elife. 2023. PMID: 37017508 Free PMC article.
Clearance pathways of near-infrared-II contrast agents.
Yang S, Li N, Xiao H, Wu GL, Liu F, Qi P, Tang L, Tan X, Yang Q. Yang S, et al. Among authors: li n. Theranostics. 2022 Nov 14;12(18):7853-7883. doi: 10.7150/thno.79209. eCollection 2022. Theranostics. 2022. PMID: 36451852 Free PMC article. Review.
New perspective of skeletal stem cells.
Yuan G, Li Z, Lin X, Li N, Xu R. Yuan G, et al. Among authors: li n. Biomater Transl. 2022 Dec 28;3(4):280-294. doi: 10.12336/biomatertransl.2022.04.007. eCollection 2022. Biomater Transl. 2022. PMID: 36846511 Free PMC article. Review.
Imaging strategies for monitoring the immune response.
Liu X, Pan L, Wang K, Pan W, Li N, Tang B. Liu X, et al. Among authors: li n. Chem Sci. 2022 Oct 7;13(44):12957-12970. doi: 10.1039/d2sc03446h. eCollection 2022 Nov 16. Chem Sci. 2022. PMID: 36425502 Free PMC article. Review.
Editorial: New molecular targets involved in lung adenocarcinoma.
Zhan X, Li N. Zhan X, et al. Among authors: li n. Front Endocrinol (Lausanne). 2023 Jan 23;14:1138849. doi: 10.3389/fendo.2023.1138849. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36755924 Free PMC article. No abstract available.
6,459 results